Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature
- PMID: 37629478
- PMCID: PMC10455429
- DOI: 10.3390/life13081620
Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature
Abstract
Among people with cystic fibrosis (CF), illness burden is multifaceted, and symptoms may fluctuate in intensity across a lifespan. Caregivers of people with CF may also experience distressing symptoms. Recent developments in CF care, including the availability of highly effective modulator therapies (HEMTs) and new palliative care guidelines promoting palliative care screening may help alleviate symptoms. The objective of this review was to present a narrative view of the recent literature on symptom burden in CF, new screening approaches informed by the Cystic Fibrosis Foundation (CFF) palliative care guidelines, and early data from studies examining the impact of HEMTs on CF symptom burden. A review of the relevant literature was conducted using Google Scholar and PubMed. Included articles covered approaches to burden assessment in CF and other chronic illnesses, epidemiology of CF symptom burden, the impact of HEMTs on symptom burden, and the CFF palliative care guidelines. A primary palliative care model implementing the CFF guidelines was also described. Results of this review show that while recent developments in CF care have led to a reduction in physical symptoms, mental health symptoms remain prevalent. Ongoing screening and triage can ensure that physical symptoms, psychological symptoms, social needs, practical problems, and communication concerns are addressed by care teams.
Keywords: cystic fibrosis; palliative care; quality of life; symptom burden.
Conflict of interest statement
A.M.G. reports personal fees from the Belgian Cystic Fibrosis Foundation/King Baudouin Foundation; grants, personal fees, and travel reimbursement from Cystic Fibrosis Foundation; grants from the Dutch Cystic Fibrosis Foundation; travel reimbursement from the European Cystic Fibrosis Society; travel reimbursement from the French Cystic Fibrosis Society; personal fees from the Italian Cystic Fibrosis Research Foundation; personal fees from Johns Hopkins University/DKBmed; grants from the National Heart, Lung, and Blood Institute; personal fees from Saudi Pediatric Pulmonology Association; grants and personal fees from Vertex Pharmaceuticals; and personal fees from Virginia Commonwealth University. The remaining authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Similar articles
-
Models of Palliative Care Delivery for Individuals with Cystic Fibrosis: Cystic Fibrosis Foundation Evidence-Informed Consensus Guidelines.J Palliat Med. 2021 Jan;24(1):18-30. doi: 10.1089/jpm.2020.0311. Epub 2020 Sep 16. J Palliat Med. 2021. PMID: 32936045 Free PMC article.
-
Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial.J Cyst Fibros. 2024 Jul;23(4):804-810. doi: 10.1016/j.jcf.2023.10.018. Epub 2023 Nov 10. J Cyst Fibros. 2024. PMID: 37951787 Clinical Trial.
-
Prevalence of unmet palliative care needs in adults with cystic fibrosis.J Cyst Fibros. 2020 May;19(3):394-401. doi: 10.1016/j.jcf.2019.11.010. Epub 2019 Dec 18. J Cyst Fibros. 2020. PMID: 31862306 Free PMC article.
-
Addressing pain in people living with cystic fibrosis: Cystic fibrosis foundation evidence-informed guidelines.J Cyst Fibros. 2025 Mar;24(2):224-235. doi: 10.1016/j.jcf.2024.11.012. Epub 2024 Dec 6. J Cyst Fibros. 2025. PMID: 39645476 Review.
-
The psychological burden of cystic fibrosis.Curr Opin Pulm Med. 2016 Mar;22(2):187-91. doi: 10.1097/MCP.0000000000000244. Curr Opin Pulm Med. 2016. PMID: 26814144 Review.
Cited by
-
The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.Ther Adv Chronic Dis. 2024 Jul 30;15:20406223241264477. doi: 10.1177/20406223241264477. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 39091508 Free PMC article.
References
-
- Kavalieratos D., Georgiopoulos A., Dhingra L., Basile M., Rabinowitz E., Hempstead S., Faro A., Dellon E.P. Models of palliative care delivery for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed consensus guidelines. J. Palliat. Med. 2020;24:18–30. doi: 10.1089/jpm.2020.0311. - DOI - PMC - PubMed
-
- Di Figlia S., Georgiopoulos A., Portenoy R., Berdella M., Friedman D., Kier C., Linnemann R., Middour-Oxler B., Walker P., Wang J., et al. Palliative care needs in cystic fibrosis (CF): Baseline data from the Improving Life with CF multi-site implementation trial for primary palliative care intervention. J. Cyst. Fibros. 2022;21:S143–S144. doi: 10.1016/S1569-1993(22)00932-8. - DOI
-
- Dhingra L., Walker P., Berdella M., Plachta A., Chen J., Fresenius A., Balzano J., Barrett M., Bookbinder M., Wilder K., et al. Addressing the burden of illness in adults with cystic fibrosis with screening and triage: An early intervention model of palliative care. J. Cyst. Fibros. 2020;19:262–270. doi: 10.1016/j.jcf.2019.08.009. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources